327 related articles for article (PubMed ID: 22543015)
21. Pursuing aldose reductase inhibitors through in situ cross-docking and similarity-based virtual screening.
Cosconati S; Marinelli L; La Motta C; Sartini S; Da Settimo F; Olson AJ; Novellino E
J Med Chem; 2009 Sep; 52(18):5578-81. PubMed ID: 19719141
[TBL] [Abstract][Full Text] [Related]
22. Residues affecting the catalysis and inhibition of rat lens aldose reductase.
Carper DA; Hohman TC; Old SE
Biochim Biophys Acta; 1995 Jan; 1246(1):67-73. PubMed ID: 7811733
[TBL] [Abstract][Full Text] [Related]
23. Studies on α-glucosidase, aldose reductase and glycation inhibitory properties of sesquiterpenes and flavonoids of Zingiber zerumbet Smith.
Ajish KR; Antu KA; Riya MP; Preetharani MR; Raghu KG; Dhanya BP; Radhakrishnan KV
Nat Prod Res; 2015; 29(10):947-52. PubMed ID: 25200721
[TBL] [Abstract][Full Text] [Related]
24. Potential use of aldose reductase inhibitors to prevent diabetic complications.
Zenon GJ; Abobo CV; Carter BL; Ball DW
Clin Pharm; 1990 Jun; 9(6):446-57. PubMed ID: 2114249
[TBL] [Abstract][Full Text] [Related]
25. Probing the ultra-high resolution structure of aldose reductase with molecular modelling and noncovalent mass spectrometry.
Darmanin C; Chevreux G; Potier N; Van Dorsselaer A; Hazemann I; Podjarny A; El-Kabbani O
Bioorg Med Chem; 2004 Jul; 12(14):3797-806. PubMed ID: 15210146
[TBL] [Abstract][Full Text] [Related]
26. Aldose reductase inhibitory effect by tectorigenin derivatives from Viola hondoensis.
Moon HI; Jung JC; Lee J
Bioorg Med Chem; 2006 Nov; 14(22):7592-4. PubMed ID: 16870454
[TBL] [Abstract][Full Text] [Related]
27. Selectivity determinants of inhibitor binding to the tumour marker human aldose reductase-like protein (AKR1B10) discovered from molecular docking and database screening.
Zhao HT; Soda M; Endo S; Hara A; El-Kabbani O
Eur J Med Chem; 2010 Sep; 45(9):4354-7. PubMed ID: 20538382
[TBL] [Abstract][Full Text] [Related]
28. A neural networks-based drug discovery approach and its application for designing aldose reductase inhibitors.
Hu L; Chen G; Chau RM
J Mol Graph Model; 2006 Jan; 24(4):244-53. PubMed ID: 16226911
[TBL] [Abstract][Full Text] [Related]
29. Molecular modeling studies of the binding modes of aldose reductase inhibitors at the active site of human aldose reductase.
Lee YS; Chen Z; Kador PF
Bioorg Med Chem; 1998 Oct; 6(10):1811-9. PubMed ID: 9839011
[TBL] [Abstract][Full Text] [Related]
30. Structure of a glutathione conjugate bound to the active site of aldose reductase.
Singh R; White MA; Ramana KV; Petrash JM; Watowich SJ; Bhatnagar A; Srivastava SK
Proteins; 2006 Jul; 64(1):101-10. PubMed ID: 16639747
[TBL] [Abstract][Full Text] [Related]
31. Aldose reductase inhibitors of plant origin.
Veeresham C; Rama Rao A; Asres K
Phytother Res; 2014 Mar; 28(3):317-33. PubMed ID: 23674239
[TBL] [Abstract][Full Text] [Related]
32. Carboxymethylated pyridoindole antioxidants as aldose reductase inhibitors: Synthesis, activity, partitioning, and molecular modeling.
Stefek M; Snirc V; Djoubissie PO; Majekova M; Demopoulos V; Rackova L; Bezakova Z; Karasu C; Carbone V; El-Kabbani O
Bioorg Med Chem; 2008 May; 16(9):4908-20. PubMed ID: 18395454
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of aldose reductase inhibition and docking studies of some secondary metabolites, isolated from Origanum vulgare L. ssp. hirtum.
Koukoulitsa C; Zika C; Geromichalos GD; Demopoulos VJ; Skaltsa H
Bioorg Med Chem; 2006 Mar; 14(5):1653-9. PubMed ID: 16249088
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and structure-activity relationship of 2-phenyliminochromene derivatives as inhibitors for aldo-keto reductase (AKR) 1B10.
Endo S; Hu D; Suyama M; Matsunaga T; Sugimoto K; Matsuya Y; El-Kabbani O; Kuwata K; Hara A; Kitade Y; Toyooka N
Bioorg Med Chem; 2013 Nov; 21(21):6378-84. PubMed ID: 24071447
[TBL] [Abstract][Full Text] [Related]
35. Mechanism of human aldehyde reductase: characterization of the active site pocket.
Barski OA; Gabbay KH; Grimshaw CE; Bohren KM
Biochemistry; 1995 Sep; 34(35):11264-75. PubMed ID: 7669785
[TBL] [Abstract][Full Text] [Related]
36. Discovery of new selective human aldose reductase inhibitors through virtual screening multiple binding pocket conformations.
Wang L; Gu Q; Zheng X; Ye J; Liu Z; Li J; Hu X; Hagler A; Xu J
J Chem Inf Model; 2013 Sep; 53(9):2409-22. PubMed ID: 23901876
[TBL] [Abstract][Full Text] [Related]
37. Design, synthesis, in vitro and in silico investigation of aldose reductase inhibitory effects of new thiazole-based compounds.
Sever B; Altıntop MD; Demir Y; Akalın Çiftçi G; Beydemir Ş; Özdemir A
Bioorg Chem; 2020 Sep; 102():104110. PubMed ID: 32739480
[TBL] [Abstract][Full Text] [Related]
38. QSAR prediction of inhibition of aldose reductase for flavonoids.
Mercader AG; Duchowicz PR; Fernández FM; Castro EA; Bennardi DO; Autino JC; Romanelli GP
Bioorg Med Chem; 2008 Aug; 16(15):7470-6. PubMed ID: 18585047
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of 3(17)alpha-hydroxysteroid dehydrogenase (AKR1C21) by aldose reductase inhibitors.
Dhagat U; Endo S; Hara A; El-Kabbani O
Bioorg Med Chem; 2008 Mar; 16(6):3245-54. PubMed ID: 18165015
[TBL] [Abstract][Full Text] [Related]
40. Structural features of the aldose reductase and aldehyde reductase inhibitor-binding sites.
El-Kabbani O; Wilson DK; Petrash M; Quiocho FA
Mol Vis; 1998 Sep; 4():19. PubMed ID: 9756955
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
